A simple, step-by-step look at how genetic information guides safer, more effective medication decisions.
A simple saliva or buccal swab is collected from the patient. Non-invasive, painless, and takes less than 2 minutes.
CLIA-certified labs extract DNA and analyze specific genes (like CYP2D6, CYP2C19) that affect drug metabolism.
Results identify metabolizer status (poor, intermediate, normal, ultra-rapid) guiding drug selection and dosing.
Right drug, right dose, right patient. Reduced adverse reactions, improved efficacy, and personalized treatment.
CYP2D6 *1/*1
Normal MetabolizerCodeine prescribed
Standard dose metabolized normally
Effective Pain ReliefCompare with a different genotype:
CYP2D6 *4/*4
Poor MetabolizerCannot convert codeine to morphine
No Pain Relief — Consider AlternativeOne test. Lifetime guidance. Better prescribing decisions.